New Options for Initial Treatment of EGFR Mutant NSCLC
Podcast | English | 45 Min
Image For Activity Cover
Credit
No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the current first-line treatment options for EGFR-mutant non-small cell lung cancer, including how new data from FLAURA2 and MARIPOSA may influence treatment approaches.

Podcast Host:
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, USA 

Podcast Guests: 

  • Natasha Leighl, MD, Thoracic Medical Oncology Group Lead, Princess Margaret Cancer Centre, Canada
  • Thomas Newsom-Davis, MD, Chelsea and Westminster Hospital, UK
Powered By